Drugs: uptravi (selexipag)titration size 200MCG 66215-0602-14, uptravi (selexipag) 800MCG 66215-0608-06, uptravi (selexipag) titration combo (200MCG and 800MCG) 66215-0628-20
Ended Awarded Last action
- Contract number
- 36C26018N0040
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $153,562
Award facts
- Contract value 100% obligated
- $153,562.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$9,309 | |
| Funding Only Action | $21,670 | |
| Original award | $141,201 |
About this award
This federal contract award to Actelion Pharmaceuticals US, Inc. provides the Department of Veterans Affairs (VA) Veterans Health Administration with the pulmonary arterial hypertension medications Uptravi (selexipag) in various dosage forms and combinations. The contract is a Blanket Purchase Agreement (BPA) call off the VA and General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a potential value of $153,562.16. The contract has no set-aside designation and was awarded on October 19, 2017 with a completion date of September 30, 2018. Actelion Pharmaceuticals, a for-profit manufacturer of pharmaceutical goods, has a history of providing specialized drug treatments to federal health facilities and correctional institutions through VA and GSA contract vehicles focused on meeting the medication needs of veteran and federal patient populations.
Quick answers
Who was awarded contract 36C26018N0040?
36C26018N0040 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 19, 2017.
How much is contract 36C26018N0040 worth?
The government has obligated $153,562 on 36C26018N0040.
Is contract 36C26018N0040 an order under another contract?
Yes. 36C26018N0040 is a BPA call under V797P5160B-VA797P16A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26018N0040 competed?
The extent of competition for 36C26018N0040 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award